19 related articles for article (PubMed ID: 9816017)
1. Pharmacokinetics and biodistribution of a new anti-episialin monoclonal antibody 139H2 in ovarian-cancer-bearing nude mice.
Molthoff CF; Pinedo HM; Schlüper HM; Boven E
Cancer Immunol Immunother; 1991; 34(3):191-7. PubMed ID: 1756536
[TBL] [Abstract][Full Text] [Related]
2. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene.
Li Y; Liu D; Chen D; Kharbanda S; Kufe D
Oncogene; 2003 Sep; 22(38):6107-10. PubMed ID: 12955090
[TBL] [Abstract][Full Text] [Related]
3. Glycosylation Changes in Brain Cancer.
Veillon L; Fakih C; Abou-El-Hassan H; Kobeissy F; Mechref Y
ACS Chem Neurosci; 2018 Jan; 9(1):51-72. PubMed ID: 28982002
[TBL] [Abstract][Full Text] [Related]
4. Anticancer immune reactivity and long-term survival after treatment of metastatic ovarian cancer with dendritic cells.
Bernal SD; Ona ET; Riego-Javier A; DE Villa R; Cristal-Luna GR; Laguatan JB; Batac ER; Canlas OQ
Oncol Lett; 2012 Jan; 3(1):66-74. PubMed ID: 22740858
[TBL] [Abstract][Full Text] [Related]
5. Mucins in cancer: function, prognosis and therapy.
Kufe DW
Nat Rev Cancer; 2009 Dec; 9(12):874-85. PubMed ID: 19935676
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of monoclonal antibody DF3 with a high molecular weight antigen expressed in human ovarian carcinomas.
Friedman EL; Hayes DF; Kufe DW
Cancer Res; 1986 Oct; 46(10):5189-94. PubMed ID: 3530435
[TBL] [Abstract][Full Text] [Related]
7. Effects of differentiating agents on cell surface expression of the breast carcinoma-associated DF3-P epitope.
Perey L; Hayes DF; Kufe D
Cancer Res; 1992 Nov; 52(22):6365-70. PubMed ID: 1384960
[TBL] [Abstract][Full Text] [Related]
8. Epithelial mucin-1 (MUC1) expression and MA5 anti-MUC1 monoclonal antibody targeting in multiple myeloma.
Burton J; Mishina D; Cardillo T; Lew K; Rubin A; Goldenberg DM; Gold DV
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3065s-3072s. PubMed ID: 10541345
[TBL] [Abstract][Full Text] [Related]
9. Identification of a family of high molecular weight tumor-associated glycoproteins.
Abe M; Kufe DW
J Immunol; 1987 Jul; 139(1):257-61. PubMed ID: 2438351
[TBL] [Abstract][Full Text] [Related]
10. Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.
Perey L; Hayes DF; Maimonis P; Abe M; O'Hara C; Kufe DW
Cancer Res; 1992 May; 52(9):2563-8. PubMed ID: 1373671
[TBL] [Abstract][Full Text] [Related]
11. Expression of the DF3-P epitope in human ovarian carcinomas.
Ichige K; Perey L; Vogel CA; Buchegger F; Kufe D
Clin Cancer Res; 1995 May; 1(5):565-71. PubMed ID: 9816017
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]